The Ensign Group Inc (ENSG)

Nov 12, 2026

Kaplan Fox & Kilsheimer LLP has filed a class action lawsuit against The Ensign Group, Inc. (NASDAQ: ENSG) on behalf of investors who purchased securities between February 10, 2022, and June 18, 2026. The lawsuit alleges that Ensign's business model involves systematic neglect of elderly patients, fraudulent practices against Medicaid and Medicare, and falsification of records. Investors have until December 7, 2026, to move the court for an opportunity to be lead plaintiff.

Nov 11, 2026

Ensign Group, Inc. Director Marivic Uychiat Pison disposed of 102 common stock shares on November 6, 2026, to cover tax withholding obligations related to a vesting restricted stock award. The shares, valued at $181.08 each, were part of an award granted on November 6, 2024, which vests in five equal annual installments. Following this transaction, Uychiat Pison retains direct ownership of 15,013 common stock shares.

Nov 11, 2026

This article provides an in-depth analysis of The Ensign Group Inc. (NASDAQ: ENSG) stock, focusing on price dynamics and execution-aware positioning. It presents key findings, including neutral near-term readings and a mid-channel oscillation pattern, and outlines three distinct AI-generated trading strategies: Position Trading, Momentum Breakout, and Risk Hedging, complete with entry, target, and stop levels. The report also offers a multi-timeframe signal analysis, detailing support and resistance levels across near-term, mid-term, and long-term horizons.

Nov 10, 2026

U.S. News & World Report has recognized 101 independently operating affiliates of The Ensign Group, Inc. as among the 2027 Best Nursing Homes. These facilities earned a "High Performing" rating, the highest distinction, for outstanding quality in short-term rehabilitation, long-term care, or both. This prestigious designation highlights the dedication of caregivers and leaders to clinical excellence and superior resident care.

Nov 9, 2026

Investors in The Ensign Group, Inc. (NASDAQ: ENSG) have until December 7, 2026, to seek the lead plaintiff role in a securities fraud class action lawsuit. The lawsuit alleges that Ensign's business model relies on neglecting elderly patients, gaming quality data, and defrauding Medicare and Medicaid, leading to a significant drop in its stock price after critical reports were published. Glancy Prongay Wolke & Rotter LLP is reminding investors of this deadline and offering to help those who suffered losses.

Nov 8, 2026

The Rosen Law Firm is reminding purchasers of The Ensign Group, Inc. (NASDAQ: ENSG) securities between February 10, 2022, and June 18, 2026, of the December 7, 2026, lead plaintiff deadline for a securities class action lawsuit. The lawsuit alleges that Ensign's business model involved systematic neglect of elderly residents and defrauding Medicaid and Medicare, among other misleading practices. Investors who purchased during this period may be entitled to compensation.

Nov 6, 2026

Bleichmar Fonti & Auld LLP reminds investors of The Ensign Group, Inc. (NASDAQ:ENSG) that they have until December 7, 2026, to apply for lead plaintiff in a securities fraud class action lawsuit. The lawsuit alleges Ensign misrepresented its business model by engaging in patient neglect, understaffing, data manipulation, improper billing, and an administrator-license rental scheme, leading to significant stock drops. Investors are encouraged to contact BFA Law to discuss their rights.

Nov 6, 2026

Pomerantz LLP has announced a class action lawsuit against The Ensign Group, Inc. (NASDAQ: ENSG), advising investors who incurred losses to contact them by the December 07, 2026 deadline to be appointed Lead Plaintiff. The lawsuit follows reports from Hunterbrook Media and Muddy Waters Research alleging inadequate patient care, data manipulation, and deception regarding Ensign's nursing home operations, which led to significant drops in the company's stock price.

Nov 5, 2026

Bernstein Liebhard LLP has issued a shareholder alert for investors of The Ensign Group, Inc. (NASDAQ: ENSG), reminding them of the December 7, 2026, deadline to file as lead plaintiff in a securities fraud class action lawsuit. The lawsuit alleges that Ensign made materially false and misleading statements about its operations and financial stability between February 10, 2022, and June 18, 2026, leading to investor losses. Shareholders who purchased ENSG shares during this period and suffered losses are encouraged to contact the firm.

Nov 3, 2026

The Rosen Law Firm is reminding investors of The Ensign Group, Inc. (NASDAQ: ENSG) who purchased securities between February 10, 2022, and June 18, 2026, about the December 7, 2026, lead plaintiff deadline for a securities fraud class action lawsuit. The lawsuit alleges that Ensign's business model involved systematic neglect of elderly residents, fraudulent practices regarding Medicaid/Medicare, and misrepresentation of nursing assistant hours and administrative oversight. Investors who suffered damages may be entitled to compensation.